Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection

Reviews in Medical Virology

Volumn 28, Issue 5, 2018, Pages

  Egilmezer, Ece ^a   Walker, Gregory J ^a   Bakthavathsalam, Padmavathy ^b   Peterson, Joshua R ^b   Gooding, J Justin ^b   Rawlinson, William ^a   Stelzer Braid, Sacha ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

influenza; point of care; systematic review

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT;

CLINICAL OUTCOME; EMBASE; HUMAN; INFLUENZA; LENGTH OF STAY; MEDICAL SUBJECT HEADINGS; MEDLINE; POINT OF CARE TESTING; PRESCRIPTION; RESPIRATORY TRACT INFECTION; REVIEW; SYSTEMATIC REVIEW; EMERGENCY HEALTH SERVICE; GENETICS; HOSPITAL EMERGENCY SERVICE; INFLUENZA A VIRUS; META ANALYSIS; POLYMERASE CHAIN REACTION; VIROLOGY;

ANTIVIRAL AGENTS; DRUG PRESCRIPTIONS; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LENGTH OF STAY; POINT-OF-CARE TESTING; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS;

EID: 85052496475     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1995     Document Type: Review

References (54)

1. World Health Organisation. Top 10 causes of death fact sheet No. 310.2018; http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed Feb 10, 2018.
2. Singh S. Middle East respiratory syndrome virus pathogenesis. Semin Respir Crit Care Med. 2016;37(4):572-577.
3. Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136-1147.
4. Taubenberger J, Morens D. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3(1):499-522.
5. Tovey ER, Stelzer-Braid S, Toelle BG, et al. Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma. J Allergy Clin Immunol. 2015;135(3):663-669.
6. World Health Organisation. Influenza (Seasonal) Fact Sheet No. 211.2018; http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed Jan 15, 2018.
7. St. Geroge K. Diagnosis of influenza virus. In: Kawaoka Y, Neumann G, eds. Influenza Virus: Methods and Protocols. Humana Press; 2012;53-69.
8. Organization WH. WHO recommendations on the use of rapid testing for influenza diagnosis. 2005; http://www.who.int/influenza/resources/documents/rapid_testing/en/. Accessed February 10, 2018.
9. Gavin PJ, Thomson RB. Review of rapid diagnostic tests for influenza. Clin Appl Immunol Rev. 2004;4(3):151-172.
10. Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2011;60(1):1-24.
11. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012;156(7):500-511.
12. Popowitch EBMM. Performance characteristics of Xpert Flu/RSV XC assay. J Clin Microbiol. 2015;53(8):2720-2721.
13. Wahrenbrock MG, Matushek S, Boonlayangoor S, Tesic V, Beavis KG, Charnot-Katsikas A. Comparison of Cepheid Xpert flu/RSV XC and BioFire FilmArray for detection of influenza a, influenza B, and respiratory syncytial virus. J Clin Microbiol. 2016;54(7):1902-1903.
14. Moher DLA, Tetzlaff J, Altman DG, PRISMA Group. Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther. 2009;89(9):873-880.
15. Group OLoEW. The Oxford levels of evidence. http://www.cebm.net/index.aspx?o=5653. Accessed February 10, 2017.
16. Brendish NJ, Malachira AK, Armstrong L, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med. 2017;5(5):401-411.
17. Nitsch-Osuch A, Kuchar E, Golebiak I, et al. Rapid influenza diagnostic tests improve suitability of antiviral treatment in hospitalized children. Adv Exp Med Biol 2017;968 (no pagination).
18. Li-Kim-Moy J, Dastouri F, Rashid H, et al. Utility of early influenza diagnosis through point-of-care testing in children presenting to an emergency department. J Paediatr Child Health. 2016;52(4):422-429.
19. Blaschke AJ, Shapiro DJ, Pavia AT, et al. A national study of the impact of rapid influenza testing on clinical care in the emergency department. J Pediatric Infect Dis Soc. 2014;3(2):112-118.
20. Jennings LC, Skopnik H, Burckhardt I, Hribar I, del Piero L, Deichmann KA. Effect of rapid influenza testing on the clinical management of paediatric influenza. Influenza Other Respi Viruses. 2009;3(3):91-98.
21. Suryaprasad A, Redd JT, Ricks PM, et al. Effect of rapid influenza diagnostic testing on antiviral treatment decisions for patients with influenza-like illness: southwestern U.S., May-December 2009. Public Health Rep. 2014;129(4):322-327.
22. Theocharis G, Vouloumanou EK, Rafailidis PI, Spiropoulos T, Barbas SG, Falagas ME. Evaluation of a direct test for seasonal influenza in outpatients. Eur J Intern Med. 2010;21(5):434-438.
23. Lim JK, Kim TH, Kilgore PE, et al. The association between influenza treatment and hospitalization-associated outcomes among Korean children with laboratory-confirmed influenza. J Korean Med Sci. 2014;29(4):485-493.
24. Trabattoni E, Le V, Pilmis B, et al. Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an emergency department. Am J Emerg Med. 2017.
25. Poehling KA, Zhu Y, Tang YW, Edwards K. Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med. 2006;160(7):713-718.
26. Nitsch-Osuch A, Stefanska I, Kuchar E, et al. Influence of rapid influenza test on clinical management of children younger than five with febrile respiratory tract infections. Adv Exp Med Biol. 2013;755:237-241.
27. Jeong HW, Heo JY, Park JS, Kim WJ. Effect of the influenza virus rapid antigen test on a physician's decision to prescribe antibiotics and on patient length of stay in the emergency department. PLoS One. 2014;9(11):e110978. https://doi.org/10.1371/journal.pone.0110978
28. Ozkaya E, Cambaz N, Coskun Y, et al. The effect of rapid diagnostic testing for influenza on the reduction of antibiotic use in paediatric emergency department. Acta Paediatr. 2009;98(10):1589-1592.
29. Tillekeratne LG, Bodinayake CK, Nagahawatte A, et al. Use of rapid influenza testing to reduce antibiotic prescriptions among outpatients with influenza-like illness in southern Sri Lanka. Am J Trop Med Hyg. 2015;93(5):1031-1037.
30. Chu HY, Englund JA, Huang D, et al. Impact of rapid influenza PCR testing on hospitalization and antiviral use: a retrospective cohort study. J Med Virol. 2015;87(12):2021-2026.
31. Bonner A, Monroe K, Talley L, Klasner A, Kimberlin D. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics. 2003;112(2):363-367.
32. Esposito S, Marchisio P, Morelli P, Crovari P, Principi N. Effect of a rapid influenza diagnosis. Arch Dis Child. 2003;88(6):525-526.
33. Jun SH, Kim JY, Yoon YH, Lim CS, Ch HJ, Choi SH. The effect of the rapid antigen test for influenza on clinical practice in the emergency department: a comparison of periods before and after the 2009 H1N1 influenza pandemic. Signa Vitae. 2016;11(1):74-89.
34. Lacroix S, Vrignaud B, Avril E, et al. Impact of rapid influenza diagnostic test on physician estimation of viral infection probability in paediatric emergency department during epidemic period. J Clin Virol. 2015;72:141-145.
35. Benito-Fernandez J, Vazquez-Ronco MA, Morteruel-Aizkuren E, et al. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Pediatr Infect Dis J. 2006;25(12):1153-1157.
36. Bhavnani D, Phatinawin L, Chantra S, Olsen SJ, Simmerman JM. The influence of rapid influenza diagnostic testing on antibiotic prescribing patterns in rural Thailand. Int J Infect Dis. 2006;11(4):355-359.
37. Falsey A, Murata Y, Walsh E. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med. 2007;167(4):354-360.
38. D'Heilly SJ, Janoff EN, Nichol P, Nichol KL. Rapid diagnosis of influenza infection in older adults: influence on clinical care in a routine clinical setting. J Clin Virol. 2008;42(2):124-128.
39. González-Del Vecchio M, Catalán P, de Egea V, et al. An algorithm to diagnose influenza infection: evaluating the clinical importance and impact on hospital costs of screening with rapid antigen detection tests. Eur J Clin Microbiol Infect Dis. 2015;34(6):1081-1085.
40. Andrews D, Chetty Y, Cooper BS, et al. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use. BMC Infect Dis. 2017;17(1):671. https:/doi.org/10.1186/s12879-017-2784-z
41. Iyer SB, Gerber MA, Pomerantz WJ, Mortensen JE, Ruddy RM. Effect of point-of-care influenza testing on management of febrile children. Acad Emerg Med. 2006;13(12):1259-1268.
42. Berthod D, Genton B, Hatz C, Blum J, de Vallière S. Ability of physicians to diagnose influenza and usefulness of a rapid influenza antigen test in febrile returning travelers: a randomized controlled trial. Travel Med Infect Dis. 2015;13(5):394-399.
43. Abanses JC, Dowd MD, Simon SD, Sharma V. Impact of rapid influenza testing at triage on management of febrile infants and young children. Pediatr Emerg Care. 2006;22(3):145-149.
44. Soto M, Sampietro-Colom L, Vilella A, et al. Economic impact of a new rapid PCR assay for detecting influenza virus in an emergency department and hospitalized patients. PLoS One. 2016;11(1):e0146620. https://doi.org/10.1371/journal.pone.0146620
45. Rogers BB, Shankar P, Jerris RC, et al. Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med. 2015;139(5):636-641.
46. Campion KSC, Keene O, Cooper C, et al. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet. 1998;352(9144):1877-1881.
47. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA. 2000;283(8):1016-1024.
48. McCullough AR, Pollack AJ, Plejdrup Hansen M, et al. Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations. Med J Aust. 2017;207(2):65-69.
49. Doan QH, Kissoon N, Dobson S, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr. 2009;154(1):91-95.
50. Ko F, Drews SJ. The impact of commercial rapid respiratory virus diagnostic tests on patient outcomes and health system utilization. Expert Rev Mol Diagn. 2017;17(10):917-931.
51. Moulick A, Richtera L, Milosavljevic V, et al. Advanced nanotechnologies in avian influenza: current status and future trends—a review. Anal Chim Acta. 2017;983:42-53.
52. Liu Y, Zhang L, Wei W, et al. Colorimetric detection of influenza A virus using antibody-functionalized gold nanoparticles. Analyst. 2015;140(12):3989-3995.
53. Zheng L, Wei J, Lv X, et al. Detection and differentiation of influenza viruses with glycan-functionalized gold nanoparticles. Biosens Bioelectron. 2017;91:46-52.
54. Ahmed SR, Kim J, Suzuki T, Lee J, Park EY. Enhanced catalytic activity of gold nanoparticle-carbon nanotube hybrids for influenza virus detection. Biosens Bioelectron. 2016;85:503-508.